News / Africa

In Cameroon, TB Vaccine Breakthrough Elusive

Tuberculosis vaccine breakthrough eludes researchers in Cameroon due to 'clever' nature of TB-causing bacteria

Multimedia

Audio

Deaths from tuberculosis are increasing in the developing world and especially in Africa.  It’s the world’s second deadliest infectious disease after HIV/AIDS.  In 2008, nearly two million people died of TB and researchers warn that mortality rates will surge further if new drugs and vaccines are not developed.

Linda is a 35-year-old Cameroonian mother of two.  She’s one of 35.000 people in the country diagnosed every year with tuberculosis, which kills some 7,000.  Her problem is compounded by the fact that she’s also infected with HIV, the virus that causes AIDS.

X-ray of patient with tuberculosis
X-ray of patient with tuberculosis

“It is very difficult,” she said. “Several times, I consider suicide but then I think about my children and want to be there for them.  I have had TB for several years and despite all the drugs, I am still ill.  The doctor says my problem is severe because I also have HIV.  I have to take countless numbers of medicines every day and sometimes I just can’t stand it.”

Like others in her condition, Linda longs for the day when an effective remedy will be found.

In early October, more than 200 researchers met for an international symposium in the Cameroonian capital, Yaounde.  They discussed the disease, but had no new drugs or vaccines to report.  They could only talk about new ways to improve existing treatments.

The meeting was hosted by the Novartis Institute for Tropical Diseases, a non-profit research organization trying to find new medicines for the treatment of neglected, infectious diseases like TB, malaria and Dengue fever.

One of the conference participants, Prof. Barry Clifton of the US National Institutes of Health, says the absence of new drugs is steadily increasing the number of deaths from TB:

“I don’t feel very optimistic about a breakthrough any time in the foreseeable future unless people put more effort and emphasis and research into tackling TB,” he said.  “At our current level, I think we’ll keep the pace to the point where we hopefully don’t have many people who don’t have any options.  But we’re not going to win the race.”

Paul Herrling in a discussion with symposium attendee
Paul Herrling in a discussion with symposium attendee

The only available vaccine for TB, known as Bacille-Calmette-Guerin (BCG) was developed almost 90 years ago.  It’s a live vaccine similar to the TB bacterium and has been improved over the years to provide immunity with the first dose.

But while it reduces risks of severe forms of TB in early childhood, it is not very effective in adults, who can be infected even if they were vaccinated in their youth. And BCG is not safe for children with HIV because it can spur the onset of the disease in those with weakened immune systems.  Across Africa, most children are given the vaccine without knowledge of their HIV status.

The link Between HIV and TB

Prof. Paul Herrling is head of the Novartis Institutes for Developing World Medical Research. He says there are a number of reasons for the current dilemma:

“The first one is that the last medicines that we had for TB are about 40 years old, and one thing that people did not know at that time is that this is a very clever bacterium and when they’re treated with the same medicines for a long time, they learn to escape it.  That’s what we call resistance,” he said.

Scientists say TB strains can vary from multi-drug resistant (MDR-TB) to extensively drug resistant (XDR-TB).

The most prominent way the TB virus gains resistance is in patients’ failing to complete their treatments.

Researchers say fighting tuberculosis is made more difficult by the increasing number of people, especially in Africa, like Linda, who are also infected with HIV.  Prof. Christopher Kuaban of the University of Yaounde in Cameroon says HIV/AIDS patients are up to 20 times more likely to develop TB than people without HIV:

“HIV is an infection that destroys your immune system. TB is contained by this immune system – so if your immune system breaks down when you’re infected by TB, the TB germ has nothing to fear because there’s nobody to destroy it. That’s why in any country where HIV is common, TB becomes very common,” he said.

Ongoing research inconclusive

Current treatment is cumbersome: it takes six to nine months and patients must take several tablets several times a day.  Research in several parts of the world is focusing on developing treatment that’s easier for the patient, as well as vaccines that may replace BCG.

Clinical trials are about to begin on one vaccine candidate - called AERAS-422.  They will be conducted in Kenya, South Africa, Uganda and India by the non-profit research organization Aeras Global TB Vaccine Foundation.  It recently obtained a $785,000 three-year-grant from the U.S. Food and Drug Administration.  Officials say the results may be available by the year 2020.

University of Yaounde (Cameroon) TB
University of Yaounde (Cameroon) TB

Funding is a problem say researchers like Barry Clifton:

“A normal pharmaceutical company will take a hundred people working for several years to get a candidate to put into clinical trials," he said. "With TB, we don’t have those kinds of resources because it’s a developing world disease, and there’s no financial incentive.  So, we try to do the best we can with the small resources we have.  It’s market-driven, so the big pharmaceutical companies are responsible for making money [for their shareholders].”

Meantime, the epidemic continues to grow, especially in Africa, where cities are increasingly crowded, where poor people find little to eat to bolster their immune systems, and where healthcare services are not adequate.

As a result, more and more people like Linda and her children are victims of stigma and discrimination. They are increasingly turning their backs on hospitals and heading for traditional healers and proliferating prayer churches for help.

TB’s intimidating complexities

TB is caused by a bacterium known as the Mycobacterium tuberculosis.  It’s spread from person to person through tiny airborne droplets of infected sputum.  It can affect almost any tissue or organ in the body, with the most common site being the lungs.  Basically, it cripples the human immune system, leaving patients vulnerable to deadly bacterial infection.

The WHO says of the nine million people diagnosed with TB worldwide last year, a third live in Africa.  It’s currently the leading cause of death among people with HIV/AIDS on the continent.

You May Like

Mood Tense Ahead of Scotland Independence Vote

As race to persuade undecided voters continues, No voters say they believe life in Scotland will slowly improve and do not want to take a risk by endorsing independence More

South Africa’s 'Open Mosque' Admits Everyone, Including Critics

Open Mosque founder plans to welcome gay worshipers and allow women to lead prayers More

Ukrainian Activist in Despair About Future of Her Country

IrIna Dovgan, accused of being a spy and tortured by pro-Russian separatists, is appealing to UN Human Rights Council to support her country More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
NASA Picks Boeing, SpaceX to Carry Astronauts Into Spacei
X
September 17, 2014 4:20 AM
The U.S. space agency, NASA, has chosen Boeing and SpaceX companies to build the next generation of spacecraft that will carry U.S. astronauts to the International Space Station by the year 2017. The deal with private industry enables NASA to end its dependence on Russia to send space crews into low Earth orbit and back. Zlatica Hoke has more.
Video

Video NASA Picks Boeing, SpaceX to Carry Astronauts Into Space

The U.S. space agency, NASA, has chosen Boeing and SpaceX companies to build the next generation of spacecraft that will carry U.S. astronauts to the International Space Station by the year 2017. The deal with private industry enables NASA to end its dependence on Russia to send space crews into low Earth orbit and back. Zlatica Hoke has more.
Video

Video Future of Ukrainian Former President's Estate Uncertain

More than six months after Ukraine's former President Viktor Yanukovych fled revolution to Russia, authorities have yet to gain control of his palatial estate. Protesters occupy the grounds and opened it to tourists but they are also refusing to turn it over to the state. VOA's Daniel Schearf reports from Mezhigirya, just north of Kyiv.
Video

Video China Muslims Work to Change Perceptions After Knife Attacks

China says its has sentenced three men to death and one woman to life in prison for a deadly knife attack in March that left more than 30 dead and 140 injured. Beijing says Muslim militants from China's restive western region of Xinjiang carried out the attacks. Now, more than six months after the incident, residents in the city are still coping with the aftermath. VOA's Bill Ide has more from Kunming.
Video

Video Enviropreneur Seeks to Save the Environment, Empower the Community

Lorna Rutto, a former banker, is now an ‘enviropreneur’ - turning plastic waste into furniture and fences discusses the challenges she faces in Africa with raw materials and the environment.
Video

Video West Trades Accusations Over Ransoms

As world leaders try to forge a common response to the threat posed by Islamic State militants in Iraq and Syria, there is simmering tension over differing policies on paying ransoms. In the past month, the jihadist group has beheaded two Americans and one Briton. Both countries refuse to pay ransom money. As Henry Ridgwell reports for VOA from London, there is uncertainty in the approach of some other European nations.
Video

Video Scotland Independence Bid Stokes Global Interest

The people of Scotland are preparing to vote on whether to become independent and break away from the rest of Britain, in a referendum being watched carefully in many other countries. Some see it as a risky experiment; while others hope a successful vote for independence might energize their own separatist demands. Foreign immigrants to Scotland have a front row seat for the vote. VOA’s Henry Ridgwell spoke to some of them in Edinburgh.
Video

Video Washington DC Mural Artists Help Beautify City

Like many cities, Washington has a graffiti problem. Buildings and homes, especially in low-income neighborhoods, are often targets of illegal artwork. But as we hear from VOA’s Julie Taboh, officials in the nation's capital have come up with an innovative program that uses the talents of local artists to beautify the city.
Video

Video US Muslim Leaders Condemn Islamic State

Leaders of America's Muslim community are condemning the violent extremism of the Islamic State group in Iraq and Syria. The U.S. Muslim leaders say militants are exploiting their faith in a failed effort to justify violent extremism. VOA correspondent Meredith Buel reports.
Video

Video Bedouin Woman Runs Successful Business in Palestinian City

A Bedouin woman is breaking social taboos by running a successful vacation resort in the Palestinian town of Jericho. Bedouins are a sub-group of Arabs known for their semi-nomadic lifestyle. Zlatica Hoke says the resort in the West Bank's Jordan Valley is a model of success for women in the region.


Carnage and mayhem are part of daily life in northern Nigeria, the result of a terror campaign by the Islamist group Boko Haram. Fears are growing that Nigeria’s government may not know how to counter it, and may be making things worse. More

AppleAndroid